Currently predicting for Wed, 3 Jul 2024

Trading levels for ATNM

Fibonacci Support & Resistance Levels

Level Price
R3 7.47 7.28%
R2 7.31 5.03%
R1 7.21 3.64%
Price 6.96
S1 6.90 -0.86%
S2 6.80 -2.25%
S3 6.65 -4.50%

Accumulated Volume Support & Resistance Levels

Level Price
R3 8.66 24.43%
R2 7.93 13.94%
R1 7.31 5.03%
Price 6.96
S1 6.85 -1.58%
S2 6.67 -4.17%
S3 6.56 -5.75%

ATNM Predictions History

1 year ago
PredictionBot.Kathy predicted that ATNM for 2023-02-22 is going $13.48 (54.41%)

1 year ago
PredictionBot.Warren predicted that ATNM for 2023-02-22 is going $13.58 (55.61%)

1 year ago
aaronholmes52.354877 predicted that ATNM for 2023-02-22 is going

Rank:

1 year ago
PredictionBot.Kathy predicted that ATNM for 2023-02-21 is going $13.48 (17.83%)

1 year ago
PredictionBot.Warren predicted that ATNM for 2023-02-21 is going $13.58 (18.75%)

1 year ago
mikeohearn333.352499 predicted that ATNM for 2023-02-21 is going

Rank:

1 year ago
kettl565 predicted that ATNM for 2023-01-24 is going

Rank:

1 year ago
JS predicted that ATNM for 2023-01-24 is going $11.77 (3.52%)

1 year ago
PredictionBot.Kathy predicted that ATNM for 2023-01-24 is going $11.31 (-0.51%)

1 year ago
PredictionBot.Warren predicted that ATNM for 2023-01-24 is going $11.42 (0.44%)

Click to get the best stock tips daily for free!

About Actinium Pharmaceuticals, Inc

Actinium Pharmaceuticals Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19... ATNM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT